Jundishapur Journal of Natural Pharmaceutical Products

Published by: Kowsar

Relapse of a Plasmodium vivax Infection in an Iranian Patient: A Case Report

Aliehsan Heidari 1 , * , Susan Sheikhi 1 , Parviz Fallah 2 and Hossein Keshavarz 3
Authors Information
1 Department of Parasitology, School of Medicine, Alborz University of Medical Sciences, Karaj, IR Iran
2 Department of Hematology, School of Paramedical Sciences, Alborz University of Medical Sciences, Karaj, IR Iran
3 Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, IR Iran
Article information
  • Jundishapur Journal of Natural Pharmaceutical Products: November 2017, 12 (4); e14499
  • Published Online: November 30, 2017
  • Article Type: Case Report
  • Received: June 3, 2017
  • Accepted: October 28, 2017
  • DOI: 10.5812/jjnpp.14499

To Cite: Heidari A, Sheikhi S, Fallah P, Keshavarz H. Relapse of a Plasmodium vivax Infection in an Iranian Patient: A Case Report, Jundishapur J Nat Pharm Prod. 2017 ; 12(4):e14499. doi: 10.5812/jjnpp.14499.

Copyright © 2017, Jundishapur Journal of Natural Pharmaceutical Products. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Introduction
2. Case Presentation
3. Discussion
  • 1. Sachs J, Malaney P. The economic and social burden of malaria. Nature. 2002;415(6872):680-5. doi: 10.1038/415680a. [PubMed: 11832956].
  • 2. Battle KE, Karhunen MS, Bhatt S, Gething PW, Howes RE, Golding N, et al. Geographical variation in Plasmodium vivax relapse. Malar J. 2014;13:144. doi: 10.1186/1475-2875-13-144. [PubMed: 24731298].
  • 3. Ehtesham R, Fazaeli A, Raeisi A, Keshavarz H, Heidari A. Detection of mixed-species infections of Plasmodium falciparum and Plasmodium vivax by nested PCR and rapid diagnostic tests in southeastern Iran. Am J Trop Med Hyg. 2015;93(1):181-5. doi: 10.4269/ajtmh.14-0650. [PubMed: 25962771].
  • 4. White NJ. Determinants of relapse periodicity in Plasmodium vivax malaria. Malar J. 2011;10:297. doi: 10.1186/1475-2875-10-297. [PubMed: 21989376].
  • 5. Andrianaranjaka V, Lin JT, Golden C, Juliano JJ, Randrianarivelojosia M. Activation of minority-variant Plasmodium vivax hypnozoites following artesunate + amodiaquine treatment in a 23-year old man with relapsing malaria in Antananarivo, Madagascar. Malar J. 2013;12:177. doi: 10.1186/1475-2875-12-177. [PubMed: 23721298].
  • 6. Durante Mangoni E, Severini C, Menegon M, Romi R, Ruggiero G, Majori G. Case report: An unusual late relapse of Plasmodium vivax malaria. Am J Trop Med Hyg. 2003;68(2):159-60. [PubMed: 12641405].
  • 7. McFarland AP, Sanchez JF, Mercado A, Ventocilla JA, Cavalcanti S, Gonzalez S, et al. Repeated Plasmodium vivax malaria relapses in a Peruvian sailor. Malar J. 2015;14:478. doi: 10.1186/s12936-015-0959-x. [PubMed: 26620122].
  • 8. Miahipour A, Keshavarz H, Heidari A, Raeisi A, Rezaeian M, Rezaei S. Assessment of the efficacy of 8 weeks of primaquine for the prevention of relapse in vivax malaria patients using SSCP-PCR and sequencing in South and South-East Iran, 2008-2011. Trans R Soc Trop Med Hyg. 2013;107(7):420-6. doi: 10.1093/trstmh/trt035. [PubMed: 23694816].
  • 9. Bright AT, Alenazi T, Shokoples S, Tarning J, Paganotti GM, White NJ, et al. Genetic analysis of primaquine tolerance in a patient with relapsing vivax malaria. Emerg Infect Dis. 2013;19(5):802-5. doi: 10.3201/eid1905.121852. [PubMed: 23648098].
  • 10. Edrissian G. Malaria in Iran, past and present situation. Iran J Parasitol. 2006;1(1):1-4.
  • 11. Snounou G, Viriyakosol S, Zhu XP, Jarra W, Pinheiro L, do Rosario VE, et al. High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction. Mol Biochem Parasitol. 1993;61(2):315-20. [PubMed: 8264734].
  • 12. Baird JK. Evidence and implications of mortality associated with acute Plasmodium vivax malaria. Clin Microbiol Rev. 2013;26(1):36-57. doi: 10.1128/CMR.00074-12. [PubMed: 23297258].
  • 13. World Health Organization . World health organization, guidelines for the treatment of malaria. 2 ed. Geneva, Switzerland: WHO; 2010.
  • 14. Ingram RJ, Crenna-Darusallam C, Soebianto S, Noviyanti R, Baird JK. The clinical and public health problem of relapse despite primaquine therapy: case review of repeated relapses of Plasmodium vivax acquired in Papua New Guinea. Malar J. 2014;13:488. doi: 10.1186/1475-2875-13-488. [PubMed: 25495607].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments